RAC 6.80% $1.89 race oncology ltd

Ann: Race Receives $4.0m R&D Tax Refund for Financial Year 2023, page-16

  1. 128 Posts.
    lightbulb Created with Sketch. 33
    I think you'll find the R&D line bears some of those costs also and it may have taken another quarter or two to flush out the invoicing. Have to ask yourself how we went through so much cash allocated to trials without actually starting those trials. I would conservatively estimate easily a few million was "effectively" spent on these consultants whose recommendations will not be used and question the usefulness of what was provided.... pretty sure no enduring benefit..... you should expect to see this in the low R&D tax refund for TY2024 vis a vis R&D spend....
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.